+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID04503577

Prospective Bladder Cancer Infrastructure Nationwide Research Network for Observational and Interventional Bladder Cancer Studies

Led by Prospective Bladder Cancer Infrastructure Foundation · Updated on 2026-09-21

3600

Participants Needed

23

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to create a nationwide group of bladder cancer patients in the Netherlands, including those with high-risk non-muscle-invasive, muscle-invasive, and metastatic stages. It focuses on gathering information to support both observational and interventional bladder cancer research. The study is sponsored by the Prospective Bladder Cancer Infrastructure Foundation and includes adults diagnosed with bladder cancer at any stage except Ta. Participants are observed over a long period, with no specific treatments or interventions assigned by the study. The infrastructure supports collecting data to study overall survival over 10 years as the primary outcome. Secondary outcomes include progression-free survival, recurrence-free survival over 10 years, and health-related quality of life assessments for 2 years. During the study, participants will have their health and cancer status monitored, and quality of life will be evaluated. Data collection may involve questionnaires and medical records over the study period. The study plans to follow participants until the end date in 2041, with a primary completion date set for the end of 2040.

CONDITIONS

Brief Title

Prospective Bladder Cancer Infrastructure (ProBCI)

Research Team

A

A. Richters, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here